Computational evaluation of 1,2,3-triazole-based VEGFR-2 inhibitors: anti-angiogenesis potential and pharmacokinetic assessment
Authors:
- 9 January 2024
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 43 (5) , 2549-2559
Abstract
The vascular endothelial growth factor (VEGF) and its cell surface receptor, as well as the human VEGFR-2 domain kinase, are some of the signaling pathways that have received the most attention in this field. This study aimed to identify novel molecules as VEGFR-2 inhibitors using 3D-QSAR modeling based on 1,2,3-triazole. Docking studies and dynamic simulations were performed to analyze novel interactions with the inhibitors and validate the molecular docking, dynamic simulations, and ADMET analyses. The optimized CoMSIA/SEH model showed good statistical results, and molecular docking and molecular dynamics simulations demonstrated stability of M3 ligand with the receptor and provided insight into ligand-receptor interactions. The newly developed compounds performed well in ADMET evaluations and showed promising results using Lipinski's rule of five, suggesting that the molecule M3 could be a useful anti-angiogenesis agent. In conclusion, this study provides insights into the structure-activity relationship of VEGFR-2 inhibitors and identifies M3 as a potential new anti-angiogenesis drug. The methodology used in this study can be applied to other similar drug targets to discover new and potent inhibitors.Communicated by Ramaswamy H. Sarma.Keywords
This publication has 31 references indexed in Scilit:
- Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domainBiochemical Journal, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Understanding and managing the possible adverse effects associated with bevacizumabAmerican Journal of Health-System Pharmacy, 2009
- Angiogenesis in life, disease and medicineNature, 2005
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- In silico prediction of blood–brain barrier permeationDrug Discovery Today, 2003
- Rigid‐body dynamics in the isothermal‐isobaric ensemble: A test on the accuracy and computational efficiencyJournal of Computational Chemistry, 2003
- Predictive ability of regression models. Part II: Selection of the best predictive PLS modelJournal of Chemometrics, 1992
- Validation of the general purpose tripos 5.2 force fieldJournal of Computational Chemistry, 1989
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983